Weekly Research Analysts’ Ratings Updates for Clorox (CLX)

Clorox (NYSE: CLX) recently received a number of ratings updates from brokerages and research firms:

  • 2/8/2018 – Clorox was downgraded by analysts at Argus from a “buy” rating to a “hold” rating. They now have a $127.81 price target on the stock, down previously from $150.40.
  • 2/6/2018 – Clorox was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $147.00 price target on the stock. According to Zacks, “Clorox delivered better-than-expected second-quarter fiscal 2018 earnings, which also marked its fifth straight earnings beat. Results gained from solid sales and lower tax rate. Sales improved year over year driven by strength in International, Lifestyle and Cleaning segments due to higher prices. Moreover, the company’s 2020 Strategy, aimed at bolstering growth for the improvement of categories and overall market share, bodes well. Moreover, the company reiterated sales guidance for fiscal 2018, while it raised the earnings view to include the benefits of the new tax reform. However, Clorox lagged the industry in the past month. The company witnessed significant pressure on gross margin in the second quarter owing to elevated input costs for commodities and tightening of transportation market, which are likely to continue hurting margins in fiscal 2018. Nonetheless, its approach to brand management and Go Lean strategy are noteworthy.”
  • 2/5/2018 – Clorox was given a new $147.00 price target on by analysts at BMO Capital Markets. They now have a “buy” rating on the stock.
  • 2/5/2018 – Clorox had its price target lowered by analysts at Bank of America Corp from $155.00 to $140.00. They now have a “neutral” rating on the stock.
  • 2/5/2018 – Clorox had its price target lowered by analysts at Morgan Stanley from $140.00 to $133.00. They now have an “equal weight” rating on the stock.
  • 1/24/2018 – Clorox was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $161.00 price target on the stock. According to Zacks, “Clorox has outperformed the industry in the last three months. The company is gaining from the 2020 Strategy, which is aimed at bolstering growth for the improvement of categories and overall market share. The company delivered a solid start to fiscal 2018 as both first-quarter fiscal 2018 earnings and sales topped estimates and improved year over year. Earnings marked the fourth straight quarterly beat, while sales surpassed estimates for the second consecutive quarter. Earnings primarily gained from solid sales and gross margin expansion, while sales was driven by growth across the United Sates and International businesses, alongside rise in volumes. Despite a strong start to fiscal 2018, the company cut its view for the fiscal due to hurricane-related impacts and the divestiture of Aplicare business. Further, inflation and high commodity and logistics costs may dent gross margin. Estimates have been stable ahead of the second quarter earnings.”
  • 1/22/2018 – Clorox was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Clorox has outperformed the industry in the last three months. The company is gaining from the 2020 Strategy, which is aimed at bolstering growth for the improvement of categories and overall market share. The company delivered a solid start to fiscal 2018 as both first-quarter fiscal 2018 earnings and sales topped estimates and improved year over year. Earnings marked the fourth straight quarterly beat, while sales surpassed estimates for the second consecutive quarter. Earnings primarily gained from solid sales and gross margin expansion, while sales was driven by growth across the United Sates and International businesses, alongside rise in volumes. Despite a strong start to fiscal 2018, the company cut its view for the fiscal due to hurricane-related impacts and the divestiture of Aplicare business. Further, inflation and high commodity and logistics costs may dent gross margin.”
  • 1/8/2018 – Clorox was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $163.00 price target on the stock. According to Zacks, “Clorox has outperformed the industry in the last three months. The company is gaining from the 2020 Strategy, which is aimed at bolstering growth for the improvement of categories and overall market share. The company delivered a solid start to fiscal 2018 as both first-quarter fiscal 2018 earnings and sales topped estimates and improved year over year. Earnings marked the fourth straight quarterly beat, while sales surpassed estimates for the second consecutive quarter. Earnings primarily gained from solid sales and gross margin expansion, while sales was driven by growth across the United Sates and International businesses, alongside rise in volumes. Despite a strong start to fiscal 2018, the company cut its view for the fiscal due to hurricane-related impacts and the divestiture of Aplicare business. Further, inflation and high commodity and logistics costs may dent gross margin.”
  • 1/4/2018 – Clorox had its “hold” rating reaffirmed by analysts at Jefferies Group LLC. They now have a $148.00 price target on the stock.
  • 1/4/2018 – Clorox had its price target raised by analysts at Wells Fargo & Co from $130.00 to $146.00. They now have a “market perform” rating on the stock.
  • 1/4/2018 – Clorox was upgraded by analysts at Bank of America Corp from an “underperform” rating to a “neutral” rating. They now have a $155.00 price target on the stock.

Clorox Co (CLX) traded down $0.54 during trading hours on Monday, hitting $128.26. The stock had a trading volume of 355,222 shares, compared to its average volume of 1,213,034. The stock has a market capitalization of $16,667.24, a price-to-earnings ratio of 21.17, a PEG ratio of 2.41 and a beta of 0.31. Clorox Co has a 52-week low of $124.09 and a 52-week high of $150.40. The company has a debt-to-equity ratio of 2.35, a quick ratio of 0.86 and a current ratio of 1.22.

Clorox (NYSE:CLX) last released its quarterly earnings data on Friday, February 2nd. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.43 billion. Clorox had a return on equity of 126.70% and a net margin of 13.21%. The business’s quarterly revenue was up .7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.14 earnings per share. equities research analysts forecast that Clorox Co will post 6.23 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 9th. Stockholders of record on Wednesday, January 24th were paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.62%. The ex-dividend date was Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is presently 55.45%.

In other news, SVP Michael R. Costello sold 10,574 shares of the stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the completion of the sale, the senior vice president now owns 34,867 shares of the company’s stock, valued at $4,742,260.67. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.00% of the company’s stock.

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Receive News & Ratings for Clorox Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply